| 5.67 Data as of Jun 18 |  0.00 / 0.00%Today’s Change | 2.85 Today|||52-Week Range 6.88 | +30.65% Year-to-Date |
| Previous close | 5.67 |
| Today’s open | n.a. |
| Day’s range | -- - -- |
| Volume | 0 |
| Average volume (3 months) | 1,753 |
| Market cap | $164.0M |
| Dividend yield | -- |
| Earnings growth (last year) | +46.21% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | 45.66 |
| Price/Book | 8.77 |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $1.9M |
| Annual profit (last year) | -$16.6M |
| Net profit margin | -883.60% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer, Executive Director & MD John W. Holaday, PhD |
Chief Operating Officer Edward M. Rudnic, PhD |
Corporate headquarters North Sydney, New South Wales (nsw) |
.
